Smead Capital Management disclosed 31 US equity positions worth $4.3bn in its Q1 2022 13F filing. Its largest position is CLRUSD at 10.3% of the reported book, followed by OXY and AXP. Versus Q4 2021 it opened 0 new positions, added to 25, reduced 6 and exited 1.
$4.3bn
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
31
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
10.3%
Largest position
The largest single position as a share of the reported equity book.
58.7%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
20
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
75
Quarters on file since Q4 2007
Quarters for which this manager's 13F holdings are on record.